Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved symbols : Kpti save search
Antengene Announces XPOVIO® Regulatory Approval in Macau for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Published: 2023-12-06 (Crawled : 09:00) - prnewswire.com
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: 0.81%
H: 8.51%
C: 3.74%
xpovio approval treatment
Antengene Announces XPOVIO® Regulatory Approval in Hong Kong for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Published: 2023-07-17 (Crawled : 01:00) - prnewswire.com
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: -1.28%
H: 4.55%
C: -0.65%
xpovio approval treatment
Antengene Announces IND Approval in China for a Phase II Study of Eltanexor (ATG-016) in Patients with High-Risk Myelodysplastic Syndromes
Published: 2022-03-30 (Crawled : 02:00) - prnewswire.com
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: -0.91%
H: 4.06%
C: -3.8%
atg-016 approval china
Antengene Announces XPOVIO® Regulatory Approval in Singapore for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Three Indications
Published: 2022-03-02 (Crawled : 01:00) - prnewswire.com
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: -28.03%
H: 1.74%
C: -16.2%
xpovio treatment approval cel t-cell
Karyopharm Receives Orphan Drug Designation from FDA for Eltanexor for the Treatment of Myelodysplastic Syndromes
Published: 2022-01-24 (Crawled : 13:00) - biospace.com/
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: 1.39%
H: 6.65%
C: 6.09%
treatment fda drug orphan drug syndros designation
Antengene Announces NDA Approval by NMPA for XPOVIO®, China's First XPO1 inhibitor, for the Treatment of Adults with Relapsed or Refractory Multiple Myeloma
Published: 2021-12-17 (Crawled : 15:30) - biospace.com/
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: -2.37%
H: 0.0%
C: 0.0%
xpovio treatment approval china
Karyopharm's Partner Antengene Receives Approval in China for XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Published: 2021-12-17 (Crawled : 14:00) - prnewswire.com
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: -2.37%
H: 0.0%
C: 0.0%
xpovio treatment approval china
Antengene Announces Approval of the Phase II Study of Selinexor for the Treatment of Myelofibrosis in China
Published: 2021-08-24 (Crawled : 01:00) - prnewswire.com
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: 1.55%
H: 0.09%
C: -3.62%
treatment fibrosis china approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-27 (Crawled : 14:58) - fda.gov
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.21%
H: 0.14%
C: -0.05%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.64%
H: 0.68%
C: 0.34%
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -0.05%
H: 1.0%
C: -2.76%
YMAB | $15.26 -0.52% -0.52% 160K
|
Health Technology
|
| O: -0.67%
H: 2.09%
C: -0.18%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.54%
H: 0.65%
C: 0.49%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -1.6%
H: 2.25%
C: 2.2%
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: -0.47%
H: 1.53%
C: -0.35%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -0.41%
H: 0.14%
C: -0.84%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 2.34%
H: 0.37%
C: -1.69%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: -0.21%
H: 4.42%
C: 2.74%
BPMC | $92.31 0.02% 0.02% 560K
|
Health Technology
|
| O: -0.12%
H: 0.58%
C: -0.16%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -1.17%
H: 2.55%
C: 0.59%
cancer approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-22 (Crawled : 11:36) - fda.gov
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.0%
H: 1.02%
C: 0.51%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.03%
H: 1.28%
C: 1.22%
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: 0.18%
H: 0.31%
C: -2.26%
YMAB | $15.26 -0.52% -0.52% 160K
|
Health Technology
|
| O: -1.57%
H: 3.71%
C: 0.43%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.45%
H: 0.12%
C: -0.6%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.36%
H: 1.56%
C: 0.9%
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: -0.53%
H: 0.38%
C: -3.01%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -0.39%
H: 0.11%
C: -0.27%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: -1.49%
H: 2.0%
C: -2.34%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.0%
H: 0.58%
C: -3.46%
BPMC | $92.31 0.02% 0.02% 560K
|
Health Technology
|
| O: -0.84%
H: 1.72%
C: 0.61%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 2.21%
H: 0.0%
C: -4.87%
cancer approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-16 (Crawled : 19:11) - fda.gov
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
| Email alert
Add to watchlist
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
| Email alert
Add to watchlist
CLVS | $0.0812 -3.94%
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
| Email alert
Add to watchlist
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
| Email alert
Add to watchlist
YMAB | $15.26 -0.52% -0.52% 160K
|
Health Technology
| Email alert
Add to watchlist
BPMC | $92.31 0.02% 0.02% 560K
|
Health Technology
| Email alert
Add to watchlist
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
| Email alert
Add to watchlist
AVEO | $15.0 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
| Email alert
Add to watchlist
cancer approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-12 (Crawled : 00:01) - fda.gov
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.98%
H: 1.2%
C: 0.36%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.15%
H: 1.19%
C: 0.66%
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -0.41%
H: 2.22%
C: -1.07%
YMAB | $15.26 -0.52% -0.52% 160K
|
Health Technology
|
| O: 0.03%
H: 1.08%
C: -0.36%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.84%
H: 0.27%
C: -0.38%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.08%
H: 1.11%
C: -1.02%
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: 0.1%
H: 1.48%
C: -3.38%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.0%
H: 0.49%
C: -1.05%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: -0.26%
H: 1.09%
C: -0.52%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 5.35%
H: 0.7%
C: -7.18%
BPMC | $92.31 0.02% 0.02% 560K
|
Health Technology
|
| O: -0.21%
H: 0.05%
C: -2.51%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 1.47%
H: 0.0%
C: -5.79%
cancer approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-09 (Crawled : 18:17) - fda.gov
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
| Email alert
Add to watchlist
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
| Email alert
Add to watchlist
CLVS | $0.0812 -3.94%
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
| Email alert
Add to watchlist
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
| Email alert
Add to watchlist
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
| Email alert
Add to watchlist
YMAB | $15.26 -0.52% -0.52% 160K
|
Health Technology
| Email alert
Add to watchlist
BPMC | $92.31 0.02% 0.02% 560K
|
Health Technology
| Email alert
Add to watchlist
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
| Email alert
Add to watchlist
AVEO | $15.0 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
cancer approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-01 (Crawled : 13:13) - fda.gov
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.0%
H: 0.87%
C: 0.71%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.6%
H: 0.48%
C: 0.21%
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -0.45%
H: 2.35%
C: 1.86%
YMAB | $15.26 -0.52% -0.52% 160K
|
Health Technology
|
| O: 0.24%
H: 3.9%
C: 3.69%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.27%
H: 0.36%
C: 0.08%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.35%
H: 3.65%
C: 3.24%
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: 0.0%
H: 3.0%
C: 3.0%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -0.05%
H: 0.49%
C: -0.08%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 0.84%
H: 1.67%
C: 0.95%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.0%
H: 1.9%
C: 0.0%
BPMC | $92.31 0.02% 0.02% 560K
|
Health Technology
|
| O: 0.0%
H: 0.67%
C: -0.34%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: -5.55%
cancer approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-06-16 (Crawled : 19:52) - fda.gov
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.22%
H: 1.28%
C: 0.88%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.16%
H: 0.21%
C: -0.39%
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: 0.0%
H: 1.87%
C: -0.04%
YMAB | $15.26 -0.52% -0.52% 160K
|
Health Technology
|
| O: 0.0%
H: 5.48%
C: 5.2%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.98%
H: 0.77%
C: 0.65%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: 0.08%
H: 2.77%
C: 2.29%
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: -0.8%
H: 6.08%
C: 5.53%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -0.29%
H: 0.84%
C: 0.3%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: -0.45%
H: 1.02%
C: 0.23%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 1.35%
H: 5.34%
C: 1.67%
BPMC | $92.31 0.02% 0.02% 560K
|
Health Technology
|
| O: -0.81%
H: 3.66%
C: -1.58%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -0.29%
H: 1.76%
C: -2.5%
cancer approval
FDA approves selinexor for refractory or relapsed multiple myeloma
Published: 2021-06-11 (Crawled : 13:47) - fda.gov
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: 1.61%
H: 0.09%
C: -3.73%
fda approval fda approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-06-09 (Crawled : 19:32) - fda.gov
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.43%
H: 3.91%
C: 2.89%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.23%
H: 3.28%
C: 2.81%
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: 1.34%
H: 2.51%
C: 1.32%
YMAB | $15.26 -0.52% -0.52% 160K
|
Health Technology
|
| O: -0.14%
H: 5.67%
C: 3.3%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.21%
H: 1.07%
C: 0.67%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.11%
H: 2.3%
C: 2.07%
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: 0.9%
H: 4.35%
C: 4.35%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.21%
H: 1.47%
C: 1.33%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 0.12%
H: 1.53%
C: 0.0%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: -3.25%
H: 2.87%
C: -2.21%
BPMC | $92.31 0.02% 0.02% 560K
|
Health Technology
|
| O: 0.04%
H: 1.73%
C: 1.34%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -0.28%
H: 1.38%
C: -0.55%
cancer approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-28 (Crawled : 18:31) - fda.gov
ALNY | $143.8 -1.55% -1.58% 390K
|
Health Technology
| Email alert
Add to watchlist
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
| Email alert
Add to watchlist
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
| Email alert
Add to watchlist
VSTM | $9.29 -3.33% -3.44% 79K
|
Health Technology
| Email alert
Add to watchlist
EXEL | $23.7 1.76% 1.73% 1.5M
|
Health Technology
| Email alert
Add to watchlist
YMAB | $15.26 -0.52% -0.52% 160K
|
Health Technology
| Email alert
Add to watchlist
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
| Email alert
Add to watchlist
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
| Email alert
Add to watchlist
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
| Email alert
Add to watchlist
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
| Email alert
Add to watchlist
BPMC | $92.31 0.02% 0.02% 560K
|
Health Technology
| Email alert
Add to watchlist
CLVS | $0.0812 -3.94%
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
| Email alert
Add to watchlist
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
RIGL | $1.125 -1.32% -1.33% 6.4M
|
Health Technology
| Email alert
Add to watchlist
AGIO | $31.67 -0.44% -0.44% 540K
|
Health Technology
| Email alert
Add to watchlist
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
| Email alert
Add to watchlist
AVEO | $15.0 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
| Email alert
Add to watchlist
cancer approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-21 (Crawled : 18:33) - fda.gov
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.22%
H: 0.97%
C: -0.65%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: -0.06%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.36%
H: 1.01%
C: -0.28%
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: 2.54%
H: 0.48%
C: -0.29%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.35%
H: 0.65%
C: -1.19%
YMAB | $15.26 -0.52% -0.52% 160K
|
Health Technology
|
| O: 0.58%
H: 1.24%
C: -1.66%
VSTM | $9.29 -3.33% -3.44% 79K
|
Health Technology
|
| O: 0.63%
H: 2.49%
C: -0.62%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
RIGL | $1.125 -1.32% -1.33% 6.4M
|
Health Technology
|
| O: 0.82%
H: 1.08%
C: -1.62%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: 0.18%
H: 0.46%
C: -1.44%
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: 0.31%
H: 1.15%
C: -1.46%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.57%
H: 0.6%
C: -1.46%
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
|
| O: 0.33%
H: 2.2%
C: 0.21%
EXEL | $23.7 1.76% 1.73% 1.5M
|
Health Technology
|
| O: 0.08%
H: 1.64%
C: 0.45%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: -2.62%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.95%
H: 1.31%
C: -2.81%
BPMC | $92.31 0.02% 0.02% 560K
|
Health Technology
|
| O: 1.12%
H: 0.84%
C: -0.08%
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
|
| O: 0.1%
H: 1.6%
C: 0.88%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 1.19%
H: 1.71%
C: -0.33%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.71%
H: 0.14%
C: -1.06%
ALNY | $143.8 -1.55% -1.58% 390K
|
Health Technology
|
| O: 0.38%
H: 1.01%
C: -0.41%
AGIO | $31.67 -0.44% -0.44% 540K
|
Health Technology
|
| O: 0.86%
H: 1.27%
C: -0.24%
cancer approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-20 (Crawled : 18:26) - fda.gov
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.22%
H: 0.97%
C: -0.65%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: -0.06%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.36%
H: 1.01%
C: -0.28%
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: 2.54%
H: 0.48%
C: -0.29%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.35%
H: 0.65%
C: -1.19%
YMAB | $15.26 -0.52% -0.52% 160K
|
Health Technology
|
| O: 0.58%
H: 1.24%
C: -1.66%
VSTM | $9.29 -3.33% -3.44% 79K
|
Health Technology
|
| O: 0.63%
H: 2.49%
C: -0.62%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
RIGL | $1.125 -1.32% -1.33% 6.4M
|
Health Technology
|
| O: 0.82%
H: 1.08%
C: -1.62%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: 0.18%
H: 0.46%
C: -1.44%
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: 0.31%
H: 1.15%
C: -1.46%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.57%
H: 0.6%
C: -1.46%
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
|
| O: 0.33%
H: 2.2%
C: 0.21%
EXEL | $23.7 1.76% 1.73% 1.5M
|
Health Technology
|
| O: 0.08%
H: 1.64%
C: 0.45%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: -2.62%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.95%
H: 1.31%
C: -2.81%
BPMC | $92.31 0.02% 0.02% 560K
|
Health Technology
|
| O: 1.12%
H: 0.84%
C: -0.08%
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
|
| O: 0.1%
H: 1.6%
C: 0.88%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 1.19%
H: 1.71%
C: -0.33%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.71%
H: 0.14%
C: -1.06%
ALNY | $143.8 -1.55% -1.58% 390K
|
Health Technology
|
| O: 0.38%
H: 1.01%
C: -0.41%
AGIO | $31.67 -0.44% -0.44% 540K
|
Health Technology
|
| O: 0.86%
H: 1.27%
C: -0.24%
cancer approval
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.